KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · XNASCIK 1877184fmd_02CGF0537C7PWR3B9BMS4GBG2WManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: May 01, 2023 to Jul 31, 2026, 10 periods
| Line item | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Total revenues | 28 | 60 | 95 |
| Cost of revenue | 27 | 36 | 46 |
| Gross profit | 0 | 24 | 49 |
| Realized investment gains (losses) | – | 0 | 0 |
| Research and development | 15 | 16 | 19 |
| Selling, general and administrative | 70 | 115 | 164 |
| Total operating expenses | 85 | 131 | 184 |
| Operating income | (85) | (106) | (135) |
| Interest expense | 6 | 8 | 8 |
| Interest and investment income | – | 3 | 8 |
| Other non-operating income (expense) | (3) | (3) | 3 |
| Income before taxes | (94) | (114) | (131) |
| Income tax expense | 0 | 0 | 0 |
| Net income from continuing operations | (94) | (114) | (132) |
| Net income | (94) | (114) | (132) |
| Net income to common shareholders | (101) | (126) | (132) |